LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10048-1 | PD184352 | CI-1040 | LSM-1048 |  | 6918454 |
| 10047-1 | Pictilisib | Pictrelisib; GDC-0941; RG-7321 | LSM-1047 |  | 17755052 |
| 10046-1 | SB590885 | LSM-42746 |  | 53239990 | |
| 10045-1 | A443654 | LSM-1045 |  | 10172943 | |
| 10041-1 | BI-2536 | NPK33-1-98-1 | LSM-1041 |  | 11364421 |
| 10040-1 | R406 | LSM-1040 |  | 11213558 | |
| 10039-1 | WH-4-025 | LSM-44937 | |||
| 10035-1 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 |  | 10196499 |
| 10032-1 | Saracatinib | AZD0530 | LSM-1032 |  | 10302451 |
| 10031-1 | KIN001-043 | LSM-42780 |  | 24906282 | |
| 10028-1 | BMS345541 | LSM-1028 |  | 9813758 | |
| 10027-1 | Crizotinib | PF02341066 | LSM-1027 |  | 11626560 |
| 10026-1 | PD173074 | LSM-1026 |  | 1401 | |
| 10025-1 | CGP60474 | MLS000911536; SMR000463552 | LSM-1025 |  | 644215 |
| 10024-1 | NVP-TAE684 | TAE-684 | LSM-1024 |  | 16038120 |
| 10023-1 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 |  | 5291 |
| 10021-1 | Tozasertib | VX680; MK-0457 | LSM-1021 |  | 5494449 |
| 10020-1 | Dasatinib | BMS-354825; Sprycel | LSM-1020 |  | 3062316 |
| 10019-1 | JW-7-24-1 | LSM-5674 |  | 69923936 | |
| 10018-1 | Neratinib | HKI-272 | LSM-42778 |  | 53398697 |
| 10017-1 | HG-6-64-01 | KIN001-206 | LSM-43248 |  | |
| 10016-1 | HG-5-88-01 | LSM-5245 |  | 25226117 | |
| 10015-1 | HG-5-113-01 | LSM-5982 |  | 25226483 | |
| 10014-1 | GW843682X | GW843682 | LSM-1014 |  | 9826308 |
| 10011-1 | Alvocidib | Flavopiridol; HMR-1275; L868275 | LSM-1011 |  | 5287969 |